Ascites Fluid and Plasma Calprotectin Concentrations in Liver Disease

References

• Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Vana L, Smith JR, Dedman, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton, Fla.: CRS Press 1990: 187–210.
   Google Scholar
• Hetland G, Talgo GJ, Fagerhol MK. Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte LI protein) from polymorphnuclear cells in vitro. Mol Pathol 1998; 51: 143–8.
   PubMedGoogle Scholar
• McNamara MP, Wiessner JH, Collins-Lech C, Hahn BL, Sohnle PG. Neutrophil death as a defence mechanism against candida albicans infections. Lancet 1988; 19: 1163–5.
   Google Scholar
• Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelomonocytic protein calprotein. Mol Pathol 1997; 50: 113–23.
   PubMedGoogle Scholar
• Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336: 763–5.
   PubMed Web of Science ®Google Scholar
• Sohnle PG, Collins-Lech C, Wiessner JH. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991; 163: 187–92.
   PubMed Web of Science ®Google Scholar
• Sohnle PG, Hahn BL. Effect of zink-reversible growth- inhibitory activity in human empyema fluid on antibiotic microbicidal activity. Antimicrob Agent Chemother 2000; 44: 139–42.
   PubMed Web of Science ®Google Scholar
• Isaksen B, Fagerhol MK. Calprotectin inhibits matrix metallo-proteinases by sequestration of zink. Mol Pathol 2001; 54: 289–92.
   PubMedGoogle Scholar
• Berntzen HB, Olmez U, Fagerhol MK, Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991; 20: 74–82.
   PubMed Web of Science ®Google Scholar
• Brun JG, Jonsson R, Hagen HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21: 733–8.
   PubMed Web of Science ®Google Scholar
• Tibbie J, Teahon K, Tjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506–13.
   PubMed Web of Science ®Google Scholar
• Tibbie JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 15–22.
   PubMed Web of Science ®Google Scholar
• Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leukocyte L1 protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357–62.
   PubMed Web of Science ®Google Scholar
• Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000; 46: 795–800.
   PubMed Web of Science ®Google Scholar
• Homann C, Garred P, Graudal N, Hasselqvist P, Christiansen M, Fagerhol MK, et al. Plasma calprotectin: a new prognostic marker of survival in alcoholic cirrhosis. Hepatology 1995; 21: 979–85.
   PubMed Web of Science ®Google Scholar
• Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–9.
   PubMed Web of Science ®Google Scholar
• Christensen E. Prognostic models in chronic liver disease: validity, usefulness and future role. J Hepatol 1997; 26: 1414–24.
   PubMed Web of Science ®Google Scholar
• Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95: 1351–5.
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Science; 1994.
   Google Scholar
• Cox DR. Regression models and life-tables (with discussion). J R Statist Soc B 1972; 34: 187–220.
   Web of Science ®Google Scholar
• Streiff MB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 2002; 35: 947–52.
   PubMed Web of Science ®Google Scholar
• Maddrey WC, Boinott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticoid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–9.
   PubMed Web of Science ®Google Scholar
• Wyke RJ. Problems of bacterial infection in patients with liver disease. Gut 1987; 28: 623–41.
   PubMed Web of Science ®Google Scholar
• Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987; 4: 8–14.
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12: 162–9.
   PubMed Web of Science ®Google Scholar
• Graudal N, Hubeck B, Bonde J, Thomsen Å Chr. The prognostic significance of bacteremia in hepatic cirrhosis. Liver 1987; 7: 137–41.
   Google Scholar
• Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27–31.
   PubMed Web of Science ®Google Scholar
• Tarao K, So K, Moroi T, Ikeuchi T, Suyama T, Endo O, Fukushima K. Detection of endotoxin in plasma and ascites fluid of patients with cirrhosis: its clinical significance. Gastroenterology 1977; 73: 539–42.
   PubMed Web of Science ®Google Scholar
• Gaeta GB, Perna P, Adinolfi LE, Ruggiero G. Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance. Digestion 1982; 23: 239–44.
   PubMed Web of Science ®Google Scholar
• Bigatello LM, Broitman SA, Fattori L, Paoli MD, Pntello M, Bevilacqua G, et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987; 82: 11–5.
   PubMed Web of Science ®Google Scholar